Back
Theravance Biopharma Vs. FibroGen Industry Stock Comparison
Sell
42
TBPH
Theravance Biopharma
Last Price:
9.46
Seasonality Move:
-14.12%
Sell
47
FGEN
FibroGen
Last Price:
1.22
Seasonality Move:
4.66%
Sell
42
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $9.47. The Score for TBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- TBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
FibroGen (FGEN)
is a Sell
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $1.21. The Score for FGEN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- FGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing slight selling pressure.
FGEN Stock Price Chart
TBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 54.37 | Buy |
| Chaikin Money Flow: | -9083 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.02 - 9.64) | Buy |
| Bollinger Bands (100): | (8.64 - 10.3) | Sell |
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 44.7 | Sell |
| Chaikin Money Flow: | 922608 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
TBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.27 | Buy |
| 20-day SMA: | 9.33 | Buy |
| 50-day SMA: | 9.11 | Buy |
| 200-day SMA: | 9.6 | Sell |
| 8-day EMA: | 9.38 | Buy |
| 20-day EMA: | 9.29 | Buy |
| 50-day EMA: | 9.25 | Buy |
| 200-day EMA: | 9.62 | Sell |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Buy |
| 20-day SMA: | 1.16 | Buy |
| 50-day SMA: | 1.66 | Sell |
| 200-day SMA: | 1.2 | Buy |
| 8-day EMA: | 1.18 | Buy |
| 20-day EMA: | 1.26 | Sell |
| 50-day EMA: | 1.46 | Sell |
| 200-day EMA: | 3.14 | Sell |
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.19 per share, an increase this year of $1.74 per share, and an increase next year of $0.97 per share.
Theravance Biopharma Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
FibroGen Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||